Global Amifostine Market Strategic Research Report

Scope of the Report

The global Amifostine market size is predicted to grow from US$ 501 million in 2025 to US$ 860 million in 2032; it is expected to grow at a CAGR of 6.2% from 2026 to 2032.

Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2025, global Amifostine production reached approximately 4.68 M unit.

The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.

At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Amifostine market?

What factors are driving Amifostine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Amifostine market opportunities vary by end market size?

How does Amifostine break out by Type, by Application?

This report presents a comprehensive overview of the global Amifostine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 400mg/Dose
• 500mg/Dose

Segment by Channel

• Direct Sales
• Distribution

Segment by Technology

• Original Drug
• Generic Drug

Segment by Application

• Advanced Ovarian Cancer
• Head and Neck Tumors
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Amifostine market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Advanced Ovarian Cancer, Head and Neck Tumors, Others evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact